Field cancerization was first described in 1953 when pathologic atypia was identified in
clinically normal tissue surrounding oropharyngeal carcinomas. The discovery of mutated …

Long-term utilization of immunosuppression in organ transplant recipients (OTRs) leads to
decreased immune-mediated tumor surveillance and development of malignant tumors. A …

The management of skin cancer in solid organ transplant recipients is a challenge to both
the dermatologist and transplant physician. Part II of this continuing medical education …

Background Unmet needs exist in actinic keratosis (AK) treatment. Daylight photodynamic
therapy (DL‐PDT) has shown good efficacy and safety results compared to conventional …

Skin cancers are the most frequent malignancies in organ transplant recipients (OTR), with
95% being nonmelanoma skin cancers (NMSC), especially squamous (SCC) and basal cell …

Renal transplant recipients (RTR) have a 50–200‐fold higher risk for nonmelanoma‐skin
cancer (NMSC) causing high rates of morbidity and sometimes mortality. Cohort‐studies …

The number of non-melanoma skin cancers is increasing worldwide, and so also the
demand for effective treatment modalities. Topical photodynamic therapy (PDT) using …

Skin cancer is a frequent complication of organ transplantation. Current guidelines advise
specialist skin surveillance but there are limited data on how these should be implemented …

Cutaneous squamous cell carcinoma is an increasing public health concern, representing
the second most common cancer in the United States. High-risk cutaneous squamous cell …

Licensed human papillomavirus (HPV) vaccines contain virus-like particles (VLPs) self-
assembled from L1 major-capsid proteins that are remarkably effective prophylactic …